Sintx Technologies (SINT) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.78% |
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | 0.54% |
| Jun 30, 2025 | -39.89% |
| Mar 31, 2025 | -34.80% |
| Dec 31, 2024 | -38.74% |
| Sep 30, 2024 | -27.13% |
| Jun 30, 2024 | -19.91% |
| Mar 31, 2024 | -22.47% |
| Dec 31, 2023 | -2.59% |
| Sep 30, 2023 | 6.52% |
| Jun 30, 2023 | 9.17% |
| Mar 31, 2023 | 19.95% |
| Dec 31, 2022 | -27.78% |
| Sep 30, 2022 | -41.44% |
| Jun 30, 2022 | -33.77% |
| Mar 31, 2022 | -34.17% |
| Dec 31, 2021 | -28.27% |
| Sep 30, 2021 | -23.79% |
| Jun 30, 2021 | 7.45% |
| Mar 31, 2021 | 86.71% |
| Dec 31, 2020 | 232.86% |
| Sep 30, 2020 | 207.92% |
| Jun 30, 2020 | 118.01% |
| Mar 31, 2020 | 49.78% |
| Dec 31, 2019 | -20.56% |
| Sep 30, 2019 | -26.39% |
| Jun 30, 2019 | -50.12% |
| Mar 31, 2019 | -30.78% |
| Dec 31, 2018 | -21.35% |
| Sep 30, 2018 | -30.11% |
| Mar 31, 2018 | -43.19% |
| Dec 31, 2017 | -44.25% |
| Sep 30, 2017 | -34.47% |
| Dec 31, 2016 | -26.77% |
| Sep 30, 2016 | -15.48% |
| Jun 30, 2016 | -31.19% |
| Dec 31, 2015 | -24.63% |
| Sep 30, 2015 | -12.18% |
| Jun 30, 2015 | -7.75% |
| Mar 31, 2015 | -0.43% |
| Dec 31, 2014 | 38.62% |